OR WAIT 15 SECS
Adopting a cloud-based solution has exponential benefits to biopharma firms.
Biotech startups have a single-minded focus: transforming the future of health and wellness. With such an ambitious goal, things like office space or on-site IT can become cumbersome and distracting. Instead, many of these companies look to co-working spaces and cloud solutions to boost their collaborative capacity.
Operating virtually is not without its challenges. For instance, co-working facilities often have minimal cybersecurity infrastructure in place. If just one employee makes a mistake, he or she might put sensitive company data and intellectual property at risk. If multiple companies are sharing the same co-working network, they become vulnerable to end users who aren't even a part of their organization.
Security is by no means the only obstacle when it comes to having a dynamic employee structure. Fostering communication and collaboration isn’t necessarily easy when people only interact through digital channels. Often, companies treat the digital workplace as they would a physical office, which can create friction and silos in everyday processes and result in missed opportunities to meet unique employee distribution.
One of our clients with employees across the U.S. has struggled with communication and collaboration in its organization. With no sense of consistency, the system felt patchworked and didn't have the capacity to serve employees. Even worse, this struggle made it difficult to keep intellectual property and data secure.
The question is whether the advantages of working virtually in the cloud outweigh the challenges. The answer: a resounding yes. Being unencumbered by a traditional office lends biotech startups greater flexibility and agility.
If biotech startups can operate from anywhere, the cloud becomes their home base. As with any mission-critical business asset, not just any option or platform will do. Moving to the cloud is important. Engineering the right kind of cloud is even more so.
This article will discuss how businesses have moved past simply looking for general benefits in their cloud services and have instead moved toward maximizing their digital transformation capabilities. It will also explain how biotech startups can use their cloud solutions for data security, scalability, and adaptability.
The case for the cloud is undeniable, especially for small and midsize biotech firms. Cloud applications are less expensive, are easier to maintain, and provide integrative cybersecurity. Don’t assume, though, that all cloud solutions are created equal.
Companies often take a set-it-and-forget-it approach to the cloud. They move forward assuming everything has been optimized and that performance, service, or security issues are automatically addressed. For example, when performance or service issues arise, cloud-based savings can quickly disappear.
The key is finding cloud solutions that meet biotech-specific needs. Data organizing, sharing, and security are essential in this business, so those should be the pillars of your cloud infrastructure.
A tailored cloud also offers unique advantages such as reduced labor costs through automation, fewer capital expenses, and lower real estate and energy spend. Moreover, new technologies deliver value to your employees immediately following implementation.
Everyone’s cloud will (and should) look a little bit different. But there are a few key components that all cloud systems should possess:
Fast-moving biotech firms might not think they have enough time to vet cloud offerings, but they don’t have time to waste on IT problems either. By establishing a strong foundation at the outset, you can better dedicate your attention and energy to what matters most.
Michael Hadley is the CEO and president of iCorps Technologies